Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 29.23%3.93B | 40.54%2.46B | 34.78%899M | -24.91%3.1B | -10.24%3.04B | -14.10%1.75B | -33.30%667M | 323.42%4.13B | 296.75%3.39B | 301.19%2.04B |
| Profit adjustment | ||||||||||
| Investment loss (gain) | -831.03%-636M | -645.95%-606M | -109.09%-1M | 111.44%84M | 121.32%87M | 119.93%111M | -26.67%11M | -280.79%-734M | -563.64%-408M | -203.15%-557M |
| Impairment and provisions: | 123.53%152M | 5.56%38M | --5M | 4.07%537M | -20.00%68M | -55.00%36M | ---- | 5.09%516M | -15.84%85M | -12.09%80M |
| -Other impairments and provisions | 123.53%152M | 5.56%38M | --5M | 4.07%537M | -20.00%68M | -55.00%36M | ---- | 5.09%516M | -15.84%85M | -12.09%80M |
| Depreciation and amortization: | -5.54%955M | -6.74%636M | -7.54%319M | -7.67%1.34B | -8.26%1.01B | -8.33%682M | -10.39%345M | -4.30%1.45B | -3.59%1.1B | -3.75%744M |
| -Depreciation | -5.54%955M | -6.74%636M | -7.54%319M | -5.80%1.33B | -8.26%1.01B | -8.33%682M | -10.39%345M | -2.88%1.41B | -3.59%1.1B | -3.75%744M |
| -Other depreciation and amortization | ---- | ---- | ---- | -85.29%5M | ---- | ---- | ---- | -40.35%34M | ---- | ---- |
| Exchange Loss (gain) | ---- | ---- | -886.21%-228M | 321.01%263M | ---- | ---- | 105.33%29M | -134.90%-119M | ---- | ---- |
| Special items | 36.14%339M | 45.29%247M | 32.76%77M | 11.69%2.76B | 137.14%249M | 178.69%170M | 114.81%58M | 17.49%2.47B | 36.36%105M | 27.08%61M |
| Operating profit before the change of operating capital | 6.37%4.74B | 0.91%2.77B | -3.51%1.07B | 4.80%8.08B | 4.31%4.46B | 16.24%2.75B | 25.71%1.11B | 156.62%7.71B | 500.84%4.27B | 437.27%2.36B |
| Change of operating capital | ||||||||||
| Accounts receivable (increase)decrease | ---- | ---- | ---- | -132.09%-95M | ---- | ---- | ---- | 147.67%296M | ---- | ---- |
| Accounts payable increase (decrease) | ---- | ---- | ---- | -33.63%752M | ---- | ---- | ---- | 123.47%1.13B | ---- | ---- |
| Cash from business operations | 6.37%4.74B | 0.91%2.77B | -3.51%1.07B | -4.40%8.74B | 4.31%4.46B | 16.24%2.75B | 25.71%1.11B | 216.15%9.14B | 500.84%4.27B | 437.27%2.36B |
| Other taxs | ---- | ---- | ---- | 304.84%251M | ---- | ---- | ---- | -24.39%62M | ---- | ---- |
| Special items of business | -45.25%196M | 24.93%466M | -119.20%-491M | 3.72%-1.47B | -63.87%358M | -78.29%373M | -123.31%-224M | -8.58%-1.53B | 618.85%991M | 561.83%1.72B |
| Net cash from operations | 2.53%4.94B | 3.78%3.24B | -34.54%580M | -2.03%7.52B | -8.53%4.81B | -23.54%3.12B | -51.95%886M | 390.66%7.67B | 912.12%5.26B | 5,902.94%4.08B |
| Cash flow from investment activities | ||||||||||
| Loan receivable (increase) decrease | 335.29%74M | 114.81%58M | 314.29%30M | 143.82%39M | 241.67%17M | 1,000.00%27M | ---14M | -340.54%-89M | -160.00%-12M | 0.00%-3M |
| Purchase of fixed assets | ---- | ---- | ---- | 1.23%-883M | ---- | ---- | ---- | 14.78%-894M | ---- | ---- |
| Purchase of intangible assets | ---- | ---- | ---- | -114.29%-15M | ---- | ---- | ---- | -75.00%-7M | ---- | ---- |
| Recovery of cash from investments | 73.44%4.14B | 108.48%4.13B | 259.98%3.03B | -13.76%2.56B | 8.40%2.39B | -10.04%1.98B | -61.73%842M | 217.18%2.97B | 287.68%2.2B | 291.81%2.2B |
| Cash on investment | -515.69%-5.65B | -213.54%-2.78B | -712.99%-2.07B | -14.48%-4.02B | 67.31%-918M | 7.90%-886M | -25,300.00%-254M | -775.06%-3.51B | -644.83%-2.81B | -1,149.35%-962M |
| Other items in the investment business | 2.24%-612M | 3.27%-414M | -5.75%-239M | 48.00%74M | -7.56%-626M | -10.31%-428M | -3.67%-226M | 233.33%50M | 29.20%-582M | 31.69%-388M |
| Net cash from investment operations | -338.37%-2.05B | 43.52%996M | 117.53%757M | -51.59%-2.24B | 171.67%860M | -18.26%694M | -82.43%348M | -182.95%-1.48B | -79.10%-1.2B | 685.52%849M |
| Net cash before financing | -49.14%2.89B | 11.01%4.24B | 8.35%1.34B | -14.81%5.28B | 39.65%5.67B | -22.63%3.82B | -67.74%1.23B | 494.72%6.2B | 2,808.67%4.06B | 6,503.90%4.93B |
| Cash flow from financing activities | ||||||||||
| Refund | -71.10%-965M | -115.15%-923M | -21.17%-166M | ---- | 90.03%-564M | 91.41%-429M | 84.59%-137M | ---- | -37.63%-5.66B | -544.13%-4.99B |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.97B | --1.97B | --1.97B |
| Dividends paid - financing | -12.27%-3.91B | -2.15%-2.14B | ---- | ---3.48B | ---3.48B | ---2.09B | ---2.09B | ---- | ---- | ---- |
| Issuance expenses and redemption of securities expenses | 61.95%-446M | 34.47%-443M | 20.96%-430M | -38.21%-1.17B | ---1.17B | ---676M | ---544M | 77.33%-848M | ---- | ---- |
| Other items of the financing business | 963.75%2.17B | 1,396.41%2.17B | -106.23%-32M | 83.48%-787M | -135.35%-251M | -125.42%-167M | 35.98%514M | -269.99%-4.76B | -85.41%710M | -38.60%657M |
| Net cash from financing operations | 42.38%-3.15B | 60.24%-1.34B | 72.19%-628M | -47.96%-5.5B | -83.76%-5.47B | -42.38%-3.36B | -254.45%-2.26B | -166.86%-3.72B | -49,683.33%-2.98B | -419.12%-2.36B |
| Effect of rate | -122.22%-2M | 1,385.71%90M | 511.76%70M | -81.71%30M | -92.62%9M | -103.87%-7M | 19.05%-17M | -44.78%164M | -44.55%122M | 154.93%181M |
| Net Cash | -227.54%-264M | 541.15%2.9B | 169.24%709M | -109.08%-225M | -80.97%207M | -82.41%452M | -119.37%-1.02B | 803.69%2.48B | 855.56%1.09B | 582.89%2.57B |
| Begining period cash | -2.41%7.52B | -2.41%7.52B | -2.41%7.52B | 51.59%7.71B | 51.59%7.71B | 51.59%7.71B | 51.59%7.71B | -1.07%5.09B | -1.07%5.09B | -1.07%5.09B |
| Items Period | -42.86%8M | -70.00%3M | 140.00%2M | 152.94%9M | --14M | --10M | ---5M | ---17M | ---- | ---- |
| Cash at the end | -8.49%7.27B | 28.78%10.52B | 24.62%8.31B | -2.41%7.52B | 26.11%7.94B | 4.20%8.17B | -35.63%6.66B | 51.59%7.71B | 20.68%6.3B | 67.44%7.84B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS |
| Audit Opinions | -- | -- | -- | Unaudited opinion | -- | -- | -- | Unaudited opinion | -- | -- |
| Auditor | -- | -- | -- | Deloitte Touche Tohmatsu, Deloitte Hua Yong Certified Public Accountants (Special General Partnership) | -- | -- | -- | Deloitte Touche Tohmatsu, Deloitte Hua Yong Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.